Cardiothoracic Surgery News and Research

RSS

NY-ESO-1 recombinant proteins to be used in clinical trials for treating melanoma and ovarian cancer

The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein-a cancer vaccine-that will be used in clinical trials for patients facing either ovarian cancer or melanoma. The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.

21 Aug 2009

New tool for virtual surgery simulates blood flow - helps plan child's delicate heart surgery

Researchers at the Georgia Institute of Technology, collaborating with pediatric cardiologists and surgeons at The Children's Hospital of Philadelphia, have developed a tool for virtual surgery that allows heart surgeons to view the predicted effects of different surgical approaches. By manipulating three-dimensional cardiac magnetic resonance images of a patient's specific anatomy, physicians can compare how alternative approaches affect blood flow and expected outcomes, and can select the best approach for each patient before entering the operating room.

12 Aug 2009

Virtual heart surgery helps plan child's surgery

Researchers at the Georgia Institute of Technology, collaborating with pediatric cardiologists and surgeons at The Children’s Hospital of Philadelphia, have developed a tool for virtual surgery that allows heart surgeons to view the predicted effects of different surgical approaches.

10 Aug 2009

Elective surgery in Canberra a waiting game

According to the latest report from the Australian Institute of Health and Welfare (AIHW) people living in Canberra wait on average 72 days for elective surgery which is more than double the national average of 34 days.

9 Jun 2009

Somanetics announces new FDA 510(K) clearance

Somanetics Corporation has announced a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the labeling for its INVOS(R) Cerebral/Somatic Oximeter.

16 Apr 2009

Molecule Thymosin beta-4 prompts damaged heart cells to repair themselves after a heart attack

A protein that the heart produces during its early development reactivates the embryonic coronary developmental program and initiates migration of heart cells and blood vessel growth after a heart attack, researchers at UT Southwestern Medical Center have found.

14 Apr 2009

Thymosin beta-4 protein prompts damaged heart cells to repair themselves after a heart attack

12 Apr 2009

Hybrid cardiac revascularization procedures

Patients with coronary artery disease -- blockages of the vessels that feed the heart -- can be treated in a number of ways.

6 Apr 2009

Should breast tissue be screened for cancer after mammoplasty?

Young women undergoing cosmetic breast reduction surgery are being screened for cancer without their informed consent, according to a paper published on bmj.com.

11 Mar 2009

Mount Sinai first in US to implant FDA-cleared ring for mitral valve repair

David H. Adams, MD, Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, performed the first two implantations of the Carpentier-Edwards Physio II ring in the United States yesterday.

24 Feb 2009

New heart valve inserted through small chest incision

When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question.

10 Feb 2009

New method for implanting aortic heart valves

An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered to patients at NewYork-Presbyterian Hospital/Columbia University Medical Center.

7 Jan 2009

Appropriate use criteria for coronary revascularization

If you're committed to fitness, the decision to climb a couple of flights of stairs rather than take the elevator is clear. But if you develop chest pain on the way up, deciding how to treat the symptoms of clogged arteries in your heart is much more complicated.

5 Jan 2009

Scientists use patient's own stem cells to treat heart failure

Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure.

17 Nov 2008

Who needs cardiac surgery?

Throughout the developed world, cardiac surgery faces increasing challenges from percutaneous intervention, currently with revascularisation, but potentially soon for valve replacement as well. The spectacular growth of PCI in the UK over the last five years is typical for many developed countries.

31 Aug 2008

Novel approach shows potential to become an emergency treatment for heart attack patients

Researchers at The Children's Hospital of Philadelphia have manipulated cell activity that occurs during the interruption of blood flow to strongly protect heart tissue in animal studies. The finding has the potential to become an emergency treatment for heart attack patients, particularly since already existing drugs might be pressed into service to produce the protective effects.

10 Jul 2008

An implantable sensor to revolutionise the management of heart disease

An implantable sensor providing 24 hour monitoring for patients with chronic heart problems will be developed thanks to a new grant, scientists announce today.

25 Jun 2008

Life after coronary bypass surgery

For many years, assumptions have lingered that Coronary Artery Bypass Surgery Grafting (CABG) produces measurable cognitive impairment, either because of the surgery or use of cardiopulmonary bypass.

4 Apr 2008

Major improvement in aortic valve surgery with new procedure

A study published recently in the Annals of Thoracic Surgery shows a 45% reduction in operative mortality in high risk patients requiring aortic valve replacement when Least Invasive Valve techniques are used compared to the conventional approach.

12 Feb 2008

Ensuring heart safety of non-heart drugs

Current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of drugs developed primarily for non-cardiovascular medical problems, according to a recent presentation made by Dr. Jeffrey Borer, an authority in cardiovascular medicine and surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.

2 Jan 2008